(Q35173837)

6 August 2017

1 reference

title

Mechanisms of anticancer drug resistance (English)

1 reference

6 August 2017

Philip J Bergman

1

1 reference

6 August 2017

publication date

1 May 2003

1 reference

Veterinary Clinics of North America: Small Animal Practice

6 August 2017

published in

1 reference

6 August 2017

volume

33

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

651-667

1 reference

Lymphomas in dogs. A morphologic, immunologic, and clinical study

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Canine malignant lymphoma: a review and comparison with human non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

An N-myristoylated protein kinase C-alpha pseudosubstrate peptide that functions as a multidrug resistance reversal agent in human breast cancer cells is not a P-glycoprotein substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Radioresistance, chemoresistance, and apoptosis resistance. The past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Multidrug resistance proteins and other drug transport-related resistance to natural product agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Factors determining cellular mechanisms of resistance to antimitotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

p53 and chemosensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Mechanisms of cancer drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Apoptosis: a link between cancer genetics and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Translational regulation as a novel mechanism for the development of cellular drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Multidrug resistance in cancer: role of ATP-dependent transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Multidrug resistance transporters and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

P-glycoprotein as a drug target in the treatment of multidrug resistant cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Drug resistance in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

The blood-brain barrier and oncology: new insights into function and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Decreased biotolerability for ivermectin and cyclosporin a in mice exposed to potent P‐glycoprotein inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Ivermectin use in collie dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Response to physostigmine administration in collie dogs exhibiting ivermectin toxicosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of collies from the northwestern United States

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Interaction of common azole antifungals with P glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Pleiotropic, multidrug-resistant phenotype and P-glycoprotein: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Modulation of multidrug resistance: at the threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Efficacy and Toxicity of Doxorubicin/Cyclophosphamide Maintenance Therapy in Dogs with Multicentric Lymphosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

New mechanisms of hormone secretion: MDR-like gene products as extrusion pumps for hormones?

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Modulation of anthracycline activity in canine mammary tumour cells in vitro by medroxyprogesterone acetate.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Monoclonal antibody C219 immunohistochemistry against P-glycoprotein: sequential analysis and predictive ability in dogs with lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Doxorubicin induced expression of P-glycoprotein in a canine osteosarcoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Molecular analysis of multidrug resistance in feline lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Clinical trials of P-glycoprotein reversal in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Multidrug Resistance in Leukemias and its Reversal

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Reversal of multidrug resistance to cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Phase I and pharmacokinetic analysis of high-dose tamoxifen and chemotherapy in normal and tumor-bearing dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Myeloprotection with drug-resistance genes

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Stem cell engraftment strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Multidrug resistance mediated by the multidrug resistance protein (MRP) gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Biology of the multidrug resistance-associated protein, MRP.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Transporter molecules in multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Major vault protein LRP-related multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Structure and mechanism of DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

The role of DNA topoisomerases II in drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Altered DNA topoisomerase II in multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Glutathione S-transferase expression in benign and malignant ovarian tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Reduced topoisomerase II and elevated alpha class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Clinical perspectives on platinum resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Doxorubicin resistance in human melanoma cells: MDR-1 and glutathione S-transferase pi gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Karnofsky memorial lecture. Ode to methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Expression of dihydrofolate reductase and multidrug resistance genes in trimetrexate-resistant human leukemia cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Cellular and molecular mechanisms of resistance to antifolate drugs: new analogues and approaches to overcome the resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Clinical Science Review: Update on Trimetrexate, a Folate Antagonist with Antineoplastic and Antiprotozoal Properties

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Clinical relevance of MGMT in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Cytostatic drug resistance: parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA-alkyltransferase and P-glycoprotein in adult patients with leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Pharmacological strategies to increase the antitumor activity of methylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Mechanisms of resistance to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by chlorpropamide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemo

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Radiation-induced apoptosis: Relevance to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Targeting apoptosis in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

The role of caspase-8 in resistance to cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

No longer a molecular black box--new clues to apoptosis and drug resistance in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Apoptotic and proliferation indexes in canine lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Apoptosis induction of POS canine osteosarcoma cells by vitamin D and retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Retinoid receptors and the induction of apoptosis in canine osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Effect of retinoids on growth inhibition of two canine melanoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

p53 expression and apoptosis in melanomas of dogs and cats

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

Inhibitory effects of glucocorticoids on proliferation of canine mast cell tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900004-4

7 January 2021

10.1016/S0195-5616(03)00004-4

Identifiers

DOI

1 reference

release_eehxaqr3x5f5xghy6xthb4iyia

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eehxaqr3x5f5xghy6xthb4iyia

24 November 2022

mapped directly with Wikidata item

1 reference